Home - Products - Tyrosine Kinase - Trk Receptor - GNF-8625 monopyridin-N-piperazine hydrochloride

GNF-8625 monopyridin-N-piperazine hydrochloride

CAS No. 2412055-62-8

GNF-8625 monopyridin-N-piperazine hydrochloride( —— )

Catalog No. M35176 CAS No. 2412055-62-8

GNF-8625 monopyridin-N-piperazine hydrochloride is a tropomyosin receptor kinase (TRK) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 131 Get Quote
5MG 200 Get Quote
10MG 321 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GNF-8625 monopyridin-N-piperazine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    GNF-8625 monopyridin-N-piperazine hydrochloride is a tropomyosin receptor kinase (TRK) inhibitor.
  • Description
    GNF-8625 monopyridin-N-piperazine hydrochloride (TRKi-2), a TRK inhibitor, which is from the patent WO 2020038415 A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    Trk Receptor
  • Recptor
    Trk receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2412055-62-8
  • Formula Weight
    479.98
  • Molecular Formula
    C25H27ClFN7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 6.67 mg/mL (13.90 mM; Ultrasonic (<60°C)
  • SMILES
    FC=1C=C([C@@H]2N(C3=NN4C(=CN=C4C=C3)C=5N=C(C=CC5)N6CCNCC6)CCC2)C=CC1.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. By Liu, Jing, et al. Preparation of tropomyosin receptor kinase degradation compounds and methods of use. WO 2020038415 A1.
molnova catalog
related products
  • (3aR)-Selitrectinib

    (6RS)-LOXO-195 is a potent and selective Trk tyrosine kinase inhibitor.

  • LOXO-195

    LOXO-195 (Selitrectinib;LOXO 195, LOXO195)?is a potent, selective, next-generation Trk tyrosine kinase inhibitor with IC50 of 0.6 nM and <2.5 nM for WT TrkA and WT TrKC, respectively.

  • Isovitexin

    Isovitexin exhibits a potential antioxidant activity with a strong antihyperglycemic action, inhibits α-glucosidase in vivo.